[208] Murri M, Leiva I,

Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: A casecontrol study. BMC Medicine. 2013;**11**:46. DOI: 10.1186/1741-7015-11-46

[209] Jandhyala SM, Madhulika A, Deepika G, Rao GV, Reddy DN, Subramanyam C, et al. Altered intestinal microbiota in patients with chronic pancreatitis: Implications in diabetes and metabolic abnormalities. Scientific Reports. 2017;**7**:43640. DOI: 10.1038/ srep43640

[210] Remely M, Aumueller E, Merold C, Dworzak S, Hippe B, Zanner J, et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene. 2014;**537**(1):85-92. DOI: 10.1016/j. gene.2013.11.081

[211] Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, et al. Role of gut microbiota in type 2 diabetes pathophysiology. eBioMedicine. 2020;**51**:102590. DOI: 10.1016/j. ebiom.2019.11.051

[212] Ionescu R, Enache R, Cretoiu S, Bogdan G. Gut microbiome changes

in gestational diabetes. International Journal of Molecular Sciences. 2022;**23**:12839. DOI: 10.3390/ ijms232112839

[213] Rahat-Rozenbloom S, Fernandes J, Cheng J, Wolever TMS. Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans. European Journal of Clinical Nutrition. 2017;**71**(8):953-958. DOI: 10.1038/ ejcn.2016.249

[214] Duran ALC, Medina MFD, Valdivieso MRA, Dunn MAE, Torres WPR, Barrera LNA, et al. Terapia incretinomimética: evidencia clínica de la eficacia de los agonistas del GLP-1R y sus efectos cardio-protectores. Revista Latinoamericana de Hipertensión. 2018;**13**(4):400-415

[215] Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Tercé F, et al. A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism. Cell Metabolism. 2017;**25**(5):1075-90.e5. DOI: 10.1016/j.cmet.2017.04.013

[216] Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, et al. Acetate mediates a microbiome-brain-βcell axis to promote metabolic syndrome. Nature. 2016;**534**(7606):213-217. DOI: 10.1038/nature18309

[217] Zhang S, Cai Y, Meng C, Ding X, Huang J, Luo X, et al. The role of the microbiome in diabetes mellitus. Diabetes Research and Clinical Practice. 2021;**172**:108645. DOI: 10.1016/j. diabres.2020.108645

[218] De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions. Microorganisms. 2021;**9**(2):353. DOI: 10.3390/ microorganisms9020353

[219] Ellis SR, Nguyen M, Vaughn AR, Notay M, Burney WA, Sandhu S, et al. The skin and gut microbiome and its role in common dermatologic conditions. Microorganisms. 2019;**7**(11):550. DOI: 10.3390/microorganisms7110550

[220] Coates M, Lee MJ, Norton D, MacLeod AS. The skin and intestinal microbiota and their specific innate immune systems. Frontiers in Immunology. 2019;**10**:2950. DOI: 10.3389/fimmu.2019.02950

[221] Nast A, Spuls PI, van der Kraaij G, Gisondi P, Paul C, Ormerod AD, et al. European S3-guideline on the systemic treatment of psoriasis vulgaris - update apremilast and secukinumab - EDF in cooperation with EADV and IPC. Journal of the European Academy of Dermatology and Venereology. 2017;**31**(12):1951-1963. DOI: 10.1111/ jdv.14454

[222] Zhang X, Shi L, Sun T, Guo K, Geng S. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiology. 2021;**21**(1):78. DOI: 10.1186/s12866-021-02125-1

[223] Tan L, Zhao S, Zhu W, Wu L, Li J, Shen M, et al. The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Experimental Dermatology. 2018;**27**(2):144-149. DOI: 10.1111/ exd.13463

[224] Hidalgo-Cantabrana C, Gómez J, Delgado S, Requena-López S, Queiro-Silva R, Margolles A, et al. Gut microbiota dysbiosis in a cohort of

*Intestinal Microbiomics in Physiological and Pathological Conditions DOI: http://dx.doi.org/10.5772/intechopen.110642*

patients with psoriasis. British Journal of Dermatology. 2019;**181**(6):1287-1295. DOI: 10.1111/bjd.17931

[225] Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis & Rheumatology. 2015;**67**(1):128-139. DOI: 10.1002/art.38892

[226] West CE, Rydén P, Lundin D, Engstrand L, Tulic MK, Prescott SL. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clinical and Experimental Allergy. 2015;**45**(9):1419-1429. DOI: 10.1111/ cea.12566

[227] Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. The Journal of Allergy and Clinical Immunology. 2012;**129**(2):434-40, 440. e1-2. DOI: 10.1016/j.jaci.2011.10.025

[228] Sator PG, Schmidt JB, Hönigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. Journal of the American Academy of Dermatology. 2003;**48**(3):352-358. DOI: 10.1067/mjd.2003.105

[229] Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrateproducing bacteria. Allergy. 2015;**70**(2):241-244. DOI: 10.1111/all.12549

[230] McCarthy S, Barrett M, Kirthi S, Pellanda P, Vlckova K, Tobin A-M, et al. Altered skin and gut microbiome in hidradenitis suppurativa. Journal of Investigative Dermatology. 2022;**142**(2):459-68.e15. DOI: 10.1016/j. jid.2021.05.036

[231] Kam S, Collard M, Lam J, Alani RM. Gut microbiome perturbations in patients with hidradenitis suppurativa: A case series. Journal of Investigative Dermatology. 2021;**141**(1):225-8.e2. DOI: 10.1016/j.jid.2020.04.017

[232] Lam SY, Radjabzadeh D, Eppinga H, Nossent YRA, van der Zee HH, Kraaij R, et al. A microbiome study to explore the gut-skin axis in hidradenitis suppurativa. Journal of Dermatological Science. 2021;**101**(3):218-220. DOI: 10.1016/j. jdermsci.2020.12.008

*Edited by Vasudeo Zambare, Mohd Fadhil Md. Din, Puja Gupta and Bhupendra Gopalbhai Prajapati*

Technological advancements in drug discovery for health and nutrition are improving human health but may lead to drug resistance, which might forebode challenges for health and the environment. Hence, it is necessary to explore and use some natural remedies such as probiotics. *Advances in Probiotics for Health and Nutrition* provides a comprehensive, techno-commercial overview of probiotics and their production, mechanisms of action, applications, and effectiveness in health and nutrition, as well as information on safety regulations in health and nutraceuticals. This book is a useful resource for researchers, academics, scientists, and budding entrepreneurs.

Published in London, UK © 2024 IntechOpen © ChrisChrisW / iStock

Advances in Probiotics for Health and Nutrition

Advances in Probiotics for

Health and Nutrition

*Edited by Vasudeo Zambare, Mohd Fadhil Md. Din, Puja Gupta* 

*and Bhupendra Gopalbhai Prajapati*